课题基金 / 基金详情

3D Bioprinted lung cancer models for drug screening

3D Bioprinted lung cancer models for drug screening
用于药物筛选的 3D 生物打印肺癌模型
批准号:
10255317
负责人:
Marc Ferrer-Alegre
金额:
$72.57万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Marc Ferrer-Alegre的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have established protocols for the bioprinting of a lung vascularized basal tissue using primary lung endothelial cells, pericytes and fibroblasts. IHC and fluroescence miscorpcopy was used to establish vasculogenesis and angiogenesis. We also developed protocols for the labeling of cancer cells with lentivirus transduced florescence proteins and monitor tumor formation in the tissue for a set of bladder cancer cells with different metastatic origen. We are also establishing a model of the lung pleural by layering primary mesothelial cells on top of the vascularized lung base tissue to create model of mesothelioma in a pleura tissue. We are also establishing protocol to layer and differentiate small airway epithelial cells (SAEC) on to create model of NSCLC. Currently, we have established protocols for SAEC growth and differentiation and we are in the process of developing protocols to assemble the complete small airway lung tissue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
3D Bioprinted skin models for drug screening
3D Bioprinted lung cancer models for drug screening
COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses
Targeting Tumor-derived exRNA-Containing microvesicles by high throughput screening
海外基金